Answers are grounded in this paper and cite their sources.
The complexes [Mo(η 3 -allyl)(CO) 2 (S 2 PX 2 )(NCMe)] (X = OEt ( 1a ), Ph ( 1b )) react with DMAD (dimethyl acetylenedicarboxylate) to give the tricarbonyl complexes [Mo(CO) 3 (S 2 PX 2 ){OC(OMe)C(allyl) CCO 2 Me}] ( 2a,b ) in a reaction involving the coupling of allyl and alkyne. Subsequent addition of PEt 3 affords crystalline, air-stable dicarbonyl complexes [Mo(CO) 2 (PEt 3 )(S 2 PX 2 ){OC(OMe)C(allyl) CCO 2 Me}] ( 3a,b ). An X-ray structural analysis of the dithiophosphinate derivative 3b reveals that the alkenyl ligand is stabilized through intramolecular coordination of one oxygen of the ester group to the metal, forming a five-membered oxametallacycle. The alkenyl ligand shows unusual trans stereochemistry in contrast to the cis disposition usually found in previous examples of metal-mediated η 3 -allyl−alkyne coupling. Demetalation of the organic moiety can be easily afforded by reaction with air or HCl gas to give the corresponding 2-allyl fumarate 4 in high yield. Regioselectivity studies employing 1-methylallyl complexes reveal that the reaction is strongly influenced by the dithio ligand bonded to molybdenum. In all cases reaction at the more substituted carbon of the allyl is favored.
No takes yet. Share an insight, caveat, or question.
Barrado et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: